Trial Profile
Prospective Study on the Vaccine Response to Meningococcal B Vaccine After Allogeneic Stem Cell Transplantation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Oct 2020
Price :
$35
*
At a glance
- Drugs Meningococcal vaccine group B (Primary)
- Indications Meningococcal group B infections
- Focus Therapeutic Use
- Acronyms MENINGREF
- 23 Oct 2020 Status changed to completed.
- 01 Apr 2019 Planned initiation date changed from 15 Jan 2019 to 1 Jun 2019.
- 28 Nov 2018 Planned initiation date changed from 15 Sep 2018 to 15 Jan 2019.